Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mapping Therapeutic Drug Monitoring Research in Low- and Middle-Income Countries: A Scoping Review (2015-2024).

Therapeutic drug monitoring·2026
Same author

Flucloxacillin plasma and urinary concentrations with and without probenecid and urinary biomarker profiles in healthy volunteers.

British journal of clinical pharmacology·2026
Same author

A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa.

The Journal of antimicrobial chemotherapy·2026
Same author

The Evolving Epidemiology of Invasive Pneumococcal Disease in Australian Children: A Multicentre Retrospective Observational Study.

Open forum infectious diseases·2026
Same author

Tobramycin pharmacokinetic and pharmacodynamic targets in people with cystic fibrosis.

British journal of clinical pharmacology·2026
Same author

Tacrolimus in Pediatric Solid Organ Transplant Recipients: A Retrospective Cohort Study.

Pediatric transplantation·2026

Related Experiment Video

Updated: May 12, 2025

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
11:28

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically

Published on: September 9, 2015

28.9K

Safe and effective use of vancomycin.

Amy Legg1,2,3,4,5,6,7,8,9, Felicia Devchand1,2,3,4,5,6,7,8,9, Amanda Gwee1,2,3,4,5,6,7,8,9

  • 1Royal Brisbane and Women's Hospital.

Australian Prescriber
|May 9, 2025
PubMed
Summary

Vancomycin drug monitoring is crucial for optimizing treatment and minimizing toxicity. Therapeutic drug monitoring, specifically the area under the curve (AUC24), is recommended over trough concentrations for better vancomycin exposure.

Keywords:
pharmacodynamicspharmacokineticstherapeutic drug monitoringvancomycin

More Related Videos

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.3K
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.1K

Related Experiment Videos

Last Updated: May 12, 2025

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
11:28

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically

Published on: September 9, 2015

28.9K
A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.3K
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.1K

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Clinical Pharmacy

Background:

  • Vancomycin is a critical antibiotic for Gram-positive infections.
  • Therapeutic drug monitoring (TDM) is advised for vancomycin use exceeding 48 hours.
  • Optimizing vancomycin exposure is essential for efficacy and safety.

Purpose of the Study:

  • To highlight the importance of vancomycin therapeutic drug monitoring.
  • To recommend the area under the concentration-time curve over 24 hours (AUC24) as the preferred monitoring parameter.
  • To discuss vancomycin-associated toxicities and risk factor modification.

Main Methods:

  • Review of current guidelines and literature on vancomycin TDM.
  • Emphasis on AUC24 monitoring for vancomycin therapy.
  • Identification of key vancomycin toxicities and nephrotoxicity risk factors.

Main Results:

  • AUC24 monitoring is superior to trough concentrations for optimizing vancomycin exposure.
  • Recommended AUC24 target range is 400-600 mg.hr/L for non-CNS infections.
  • Vancomycin can cause nephrotoxicity, ototoxicity, and other adverse effects.

Conclusions:

  • Optimized vancomycin dosing through AUC24 monitoring improves therapeutic outcomes.
  • Vigilance for and management of vancomycin-induced toxicities, particularly nephrotoxicity, are critical.
  • Personalized vancomycin therapy based on TDM is essential for patient safety.